- Home
- AUTL vs ORC Comparison
AUTL vs ORC Comparison
Compare AUTL & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- ORC
- Stock Information
- Founded
- AUTL 2014
- ORC 2010
- Country
- AUTL United Kingdom
- ORC United States
- Employees
- AUTL N/A
- ORC N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- ORC Real Estate Investment Trusts
- Sector
- AUTL Health Care
- ORC Real Estate
- Exchange
- AUTL Nasdaq
- ORC Nasdaq
- Market Cap
- AUTL 590.8M
- ORC 623.6M
- IPO Year
- AUTL 2018
- ORC 2013
- Fundamental
- Price
- AUTL $2.19
- ORC $8.03
- Analyst Decision
- AUTL Strong Buy
- ORC Buy
- Analyst Count
- AUTL 3
- ORC 2
- Target Price
- AUTL $10.20
- ORC $9.50
- AVG Volume (30 Days)
- AUTL 1.4M
- ORC 2.6M
- Earning Date
- AUTL 03-13-2025
- ORC 01-30-2025
- Dividend Yield
- AUTL N/A
- ORC 17.93%
- EPS Growth
- AUTL N/A
- ORC N/A
- EPS
- AUTL N/A
- ORC 1.01
- Revenue
- AUTL $10,091,000.00
- ORC $75,695,000.00
- Revenue This Year
- AUTL $851.83
- ORC N/A
- Revenue Next Year
- AUTL $264.18
- ORC N/A
- P/E Ratio
- AUTL N/A
- ORC $7.93
- Revenue Growth
- AUTL 82.71
- ORC N/A
- 52 Week Low
- AUTL $2.07
- ORC $7.41
- 52 Week High
- AUTL $7.37
- ORC $9.08
- Technical
- Relative Strength Index (RSI)
- AUTL 37.25
- ORC 59.14
- Support Level
- AUTL $2.18
- ORC $7.47
- Resistance Level
- AUTL $2.38
- ORC $8.03
- Average True Range (ATR)
- AUTL 0.16
- ORC 0.14
- MACD
- AUTL 0.01
- ORC 0.02
- Stochastic Oscillator
- AUTL 3.17
- ORC 88.89
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.